We are live on
!
Find out more
PC
Paulson & Co Portfolio holdings
AUM
$3.11B
1-Year Est. Return
94.93%
This Fund
S&P 500
This Quarter
Est. Return
+15.49%
1 Year Est. Return
+94.93%
3 Year Est. Return
+233.32%
5 Year Est. Return
+258.51%
10 Year Est. Return
+934.97%
AUM
$4.35B
AUM Growth
+$502M
(+13%)
Cap. Flow
+$102M
Cap. Flow
% of AUM
2.34%
Top 10 Holdings %
Top 10 Hldgs %
74.92%
Holding
39
New
3
Increased
5
Reduced
3
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$178M |
| 2 |
PPTA
Perpetua Resources
PPTA
|
+$144M |
| 3 |
Occidental Petroleum
OXY
|
+$45.4M |
| 4 |
TIM SA
TIMB
|
+$35.5M |
| 5 |
MIK
Michaels Stores, Inc
MIK
|
+$35.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$181M |
| 2 |
Takeda Pharmaceutical
TAK
|
+$118M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$58.5M |
| 4 |
AEL
American Equity Investment Life Holding Company
AEL
|
+$27.7M |
| 5 |
Thryv Holdings
THRY
|
+$8.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 51.7% |
| 2 | Materials | 18.63% |
| 3 | Financials | 9.36% |
| 4 | Communication Services | 4.03% |
| 5 | Energy | 3.47% |
Similar funds
TCG
CCI
KF
AWM
DIG
EAM
LFG
DCM
Paulson & Co's Q1 2021 Portfolio in Review
As of Q1 2021, Paulson & Co held 39 positions worth $4.35B, up 13% from $3.85B the previous quarter. Its ten largest holdings account for 75% of the portfolio.
Paulson & Co's Q1 2021 filing shows 3 new, 5 increased, 3 reduced and 3 closed positions. Its largest new stake was Perpetua Resources: 20,935,732 shares worth $160M. The largest sale was Discovery, Inc. Series C Common Stock, an estimated $181M.
By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 47% a quarter earlier, followed by Materials and Financials.
- Paulson & Co's largest Q1 2021 buy was Perpetua Resources: 20,935,732 shares worth $160M.
- Paulson & Co added most to Alexion Pharmaceuticals in Q1 2021, an estimated $178M increase.
- Paulson & Co's biggest Q1 2021 reduction was Takeda Pharmaceutical, cutting an estimated $118M.
- Paulson & Co fully exited Discovery, Inc. Series C Common Stock in Q1 2021, selling an estimated $181M.
- Paulson & Co's ten largest holdings make up 75% of its $4.35B portfolio in Q1 2021.
- Paulson & Co opened 3 new positions and closed 3 in Q1 2021.
- Paulson & Co's portfolio value rose 13% quarter-over-quarter to $4.35B.
Based on Paulson & Co's 13F filing for Q1 2021, filed 17 May 2021.